SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

Co-Diagnostics, Inc. (CODX) News

Track canonical SquawkNews coverage tagged to CODX, Co-Diagnostics, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 26 indexed stories across 19 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol CODX Asset equity Sector Markets 90 days 23 Last 1.095 Updated Sep 23, 2026, 01:01 PM UTC Open live news feed
L CODX - Co-Diagnostics to Participate in Global Health Events During UN General Assembly Week CODX - Co-Diagnostics to Participate in Global Health Events During UN General Assembly Week NEWS | Sep 23, 2026, 01:01 PM UTC L CODX - Co-Diagnostics to Participate in Global Health Roundtable on Ebola and Outbreak Innovation CODX - Co-Diagnostics to Participate in Global Health Roundtable on Ebola and Outbreak Innovation NEWS | Sep 21, 2026, 01:01 PM UTC L CODX - Co-Diagnostics to Participate in Joint WHO/Unitaid/UNAIDS Annual Consultation Meeting on September 17-18, 2026 CODX - Co-Diagnostics to Participate in Joint WHO/Unitaid/UNAIDS Annual Consultation Meeting on September 17-18, 2026 NEWS | Sep 17, 2026, 01:04 PM UTC L Co-Diagnostics, ReadyGo to evaluate decentralized Ebola testing Co-Diagnostics said it is collaborating with ReadyGo to evaluate GoCollect blood sample prep with the Co-Dx PCR platform for decentralized Ebola testing. EQUITY | Sep 16, 2026, 12:53 PM UTC L CODX - Co-Diagnostics and ReadyGo Collaborate to Evaluate Blood-Based Molecular Testing at the Point of Need, Starting with Ebola CODX - Co-Diagnostics and ReadyGo Collaborate to Evaluate Blood-Based Molecular Testing at the Point of Need, Starting with Ebola NEWS | Sep 16, 2026, 12:45 PM UTC L CODX - Co-Diagnostics to Hold Press Conference CODX - Co-Diagnostics to Hold Press Conference NEWS | Sep 15, 2026, 08:15 PM UTC L CODX - Co-Diagnostics Completes New Vector Smart® Laboratory Installations Amid Rising Dengue Activity in Florida CODX - Co-Diagnostics Completes New Vector Smart® Laboratory Installations Amid Rising Dengue Activity in Florida EQUITY | Sep 10, 2026, 01:02 PM UTC M Co-Diagnostics completes two Vector Smart® laboratory installations in Florida Co-Diagnostics completed two full laboratory installations in Florida, with installation and customer training underway in Indiana. The company says state surveillance recorded 73 locally acquired dengue cases and identi EQUITY | Sep 10, 2026, 01:00 PM UTC L Co-Diagnostics CFO Brian Brown steps down effective September 2 Co-Diagnostics’ CFO Brian Brown stepped down effective September 2. EQUITY | Sep 04, 2026, 08:38 PM UTC L Co-Diagnostics launches integrated cloud and mobile infrastructure in India Co-Diagnostics launches integrated cloud and mobile infrastructure in India. EQUITY | Sep 03, 2026, 01:01 PM UTC L Co-Diagnostics rolls out integrated cloud and mobile infrastructure in India Co-Diagnostics says it has launched an integrated cloud and mobile infrastructure in India, with a localized cloud environment to support ongoing clinical studies and a digital foundation for future data commercializatio EQUITY | Sep 03, 2026, 01:00 PM UTC L CODX - Co-Diagnostics Expands Vector Smart® Customer Reach with First International Installation in USAF Base CODX - Co-Diagnostics Expands Vector Smart® Customer Reach with First International Installation in USAF Base EQUITY | Sep 01, 2026, 01:30 PM UTC L Co-Diagnostics installs Vector Smart at USAF base in first international move Co-Diagnostics says it has completed its first international installation of Vector Smart at a USAF base in the USA and is shipping laboratory equipment and mosquito abatement materials to the base. EQUITY | Sep 01, 2026, 01:30 PM UTC L NBIS closes $5.75 billion private convertible note offering NBIS closes a private offering of convertible senior notes with aggregate gross proceeds of approximately $5.75 billion, while multiple other companies file shelf and registration statements. EQUITY | Aug 25, 2026, 09:46 AM UTC L Co-Diagnostics files S-3 for 3,404,724 secondary shares Co-Diagnostics files a Form S-3 covering 3,404,724 shares of common stock offered by selling stockholders. REGULATION | Aug 24, 2026, 08:32 PM UTC L CODX - Co-Diagnostics Participates in Medical Devices and Innovations Roundtable Media Event CODX - Co-Diagnostics Participates in Medical Devices and Innovations Roundtable Media Event EQUITY | Aug 18, 2026, 01:30 PM UTC L Co-Diagnostics (CODX) reports Q2 2026 financial results Co-Diagnostics reports its second quarter 2026 financial results, according to TradeXchange Newsdesk. EARNINGS | Aug 13, 2026, 08:01 PM UTC L CODX CODX - Co-Diagnostics Submits FDA 510 (k) Premarket Notification for Upper Respiratory Point-of-Care Test CODX CODX - Co-Diagnostics Submits FDA 510 (k) Premarket Notification for Upper Respiratory Point-of-Care Test REGULATION | Aug 06, 2026, 01:30 PM UTC L CODX CODX - Co-Diagnostics Announces Second Quarter 2026 Earnings Release Date and Webcast CODX CODX - Co-Diagnostics Announces Second Quarter 2026 Earnings Release Date and Webcast EARNINGS | Jul 30, 2026, 01:01 PM UTC L CODX CODX - Co-Diagnostics Joint Venture CoSara Provides Ebola Test Kits for Analytical Studies CODX CODX - Co-Diagnostics Joint Venture CoSara Provides Ebola Test Kits for Analytical Studies EQUITY | Jul 28, 2026, 12:01 PM UTC L CODX Co-diagnostics - Co-dx pcr platform products to be manufactured and distributed in India under cosara brand CODX Co-diagnostics - Co-dx pcr platform products to be manufactured and distributed in India under cosara brand EQUITY | Jul 22, 2026, 01:01 PM UTC L CODX Co-diagnostics Joint venture cosara initiates clinical studies in India for tuberculosis test on pcr platform CODX Co-diagnostics Joint venture cosara initiates clinical studies in India for tuberculosis test on pcr platform EQUITY | Jul 22, 2026, 01:00 PM UTC H EXCLUSIVE: Co-Diagnostics Marks New Milestone as India TB Test Clinical Studies Begin Co-Diagnostics Inc. (NASDAQ: CODX ) on Wednesday said CoSara Diagnostics Pvt. Ltd, its joint venture in India, is initiating clinical studies for the tuberculosis test on the CoSara PCR Pro instrument. The molecular diag EARNINGS | Jul 22, 2026, 12:46 PM UTC H 'White House Adds Pandemic Response Staff as Ebola Cases Rise' - Bloomberg News 'White House Adds Pandemic Response Staff as Ebola Cases Rise' - Bloomberg News GEOPOLITICS | Jul 01, 2026, 04:19 PM UTC L EXCLUSIVE: Co-Diagnostics Completes Clinical and Analytical Studies of Upper Respiratory Point-of-Care Test Ahead Of FDA Submission Planned EXCLUSIVE: Co-Diagnostics Completes Clinical and Analytical Studies of Upper Respiratory Point-of-Care Test Ahead Of FDA Submission Planned In Q3 2026 REGULATION | Jul 01, 2026, 12:45 PM UTC